Form 8-K - Current report:
SEC Accession No. 0001193125-21-056933
Filing Date
2021-02-25
Accepted
2021-02-25 16:04:46
Documents
14
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d83170d8k.htm   iXBRL 8-K 26630
2 EX-99.1 d83170dex991.htm EX-99.1 112782
6 GRAPHIC g83170dsp04.jpg GRAPHIC 3952
  Complete submission text file 0001193125-21-056933.txt   282117

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cers-20210225.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cers-20210225_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cers-20210225_pre.xml EX-101.PRE 11401
7 EXTRACTED XBRL INSTANCE DOCUMENT d83170d8k_htm.xml XML 3390
Mailing Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520
Business Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520 9252886000
CERUS CORP (Filer) CIK: 0001020214 (see all company filings)

EIN.: 680262011 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21937 | Film No.: 21680208
SIC: 3841 Surgical & Medical Instruments & Apparatus